Graphene-Reinforced CAD/CAM Restorations for MIH-Affected Molars in Adolescents: A Prospective Clinical Study
Clinical Evaluation of Graphene-Reinforced CAD/CAM Indirect Restorations in Molars Affected by Molar-Incisor Hypomineralization (MIH) in Adolescents: A Clinical Study
1 other identifier
interventional
30
1 country
1
Brief Summary
This study evaluates the clinical performance, marginal integrity, surface wear, color stability, and postoperative sensitivity of graphene-reinforced CAD/CAM indirect restorations (inlays, onlays, overlays) in molars affected by moderate to severe Molar-Incisor Hypomineralization (MIH) in adolescents. A total of 30 patients aged 10-16 years will receive minimally invasive indirect restorations fabricated from a nano-reinforced graphene polymer (G-CAM®). Clinical outcomes will be assessed using FDI criteria, VAS sensitivity scores, patient satisfaction, and digital 3D scans over a 12-month follow-up. The study aims to determine clinical acceptability and safety compared with historical outcomes reported for composite and lithium-disilicate indirect restorations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2025
CompletedFirst Posted
Study publicly available on registry
January 9, 2026
CompletedStudy Start
First participant enrolled
January 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 23, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 11, 2027
ExpectedJanuary 9, 2026
December 1, 2025
3 months
November 30, 2025
December 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Clinical Acceptability Assessed by the FDI World Dental Federation Clinical Criteria Score
Clinical performance of the indirect CAD/CAM graphene-reinforced restoration will be evaluated using the FDI World Dental Federation Clinical Criteria. Each domain is scored on a 1-5 ordinal scale, where: 1. = Clinically excellent (best outcome) 2. = Clinically good 3. = Clinically acceptable 4. = Clinically unsatisfactory 5. = Clinically poor (worst outcome) Domains assessed: Marginal integrity Surface roughness/wear Color stability Fractures/chipping Proximal contact Occlusion/function Soft tissue response Higher scores indicate worse clinical performance. Data will be reported as mean score per domain and global acceptability.
12 months after restoration placement
Postoperative Sensitivity Measured by Visual Analog Scale (VAS 0-10)
Postoperative sensitivity to cold and mastication will be measured on a 0-10 Visual Analog Scale (VAS), where: 0 = No pain (best outcome) 10 = Worst imaginable pain (worst outcome) Higher scores indicate worse sensitivity.
Baseline (preoperative), 48 hours, 1 month, 3 months, 6 months, and 12 months
Secondary Outcomes (2)
Patient Satisfaction Measured by 5-Point Likert Scale
1 month, 3 months, 6 months, and 12 months
Change in Tooth Structure Volume Measured by 3D Intraoral Scan Superimposition (mm³)
Baseline and 12 months
Study Arms (1)
Graphene-Reinforced CAD/CAM Indirect Restoration
EXPERIMENTALMinimally invasive preparation, composite base build-up when indicated, adhesive protocol with total-etch technique, CAD/CAM fabrication using graphene-reinforced polymer (G-CAM®), adhesive cementation under rubber dam isolation, finishing and polishing, and follow-up at 1 week, 3, 6, and 12 months.
Interventions
Graphene-reinforced CAD/CAM polymer (G-CAM®) used for the fabrication of indirect inlay, onlay, or overlay restorations in permanent molars affected by molar-incisor hypomineralization (MIH). Restorations are fabricated using a digital CAD/CAM workflow and adhesively cemented under rubber dam isolation according to the study protocol.
Eligibility Criteria
You may qualify if:
- Adolescents aged 10-16 years.
- Permanent molars with moderate or severe MIH (EAPD criteria).
- Vital and restorable teeth.
- Ability to attend follow-up visits.
- Informed consent from guardian + assent from the minor.
You may not qualify if:
- Fluorosis, amelogenesis imperfecta, or other enamel defects.
- Severe bruxism not controlled.
- Active extensive caries or irreversible pulpitis.
- Systemic conditions affecting enamel or healing.
- Hypersensitivity/allergy to materials/adhesives.
- Use of analgesics/AINEs \<24 h before baseline VAS.
- Orthodontic bands on the study molar.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dental Esthetic BCN
Sarrià-Sant Gervasi, Barcelona, 08034, Spain
Related Publications (2)
Mendonca FL, Grizzo IC, Alencar CRB, Rios D. Restorative Therapy of MIH-Affected Molars. Monogr Oral Sci. 2024;32:236-260. doi: 10.1159/000538890. Epub 2024 Jul 1.
PMID: 39321762BACKGROUNDSomani C, Taylor GD, Garot E, Rouas P, Lygidakis NA, Wong FSL. An update of treatment modalities in children and adolescents with teeth affected by molar incisor hypomineralisation (MIH): a systematic review. Eur Arch Paediatr Dent. 2022 Feb;23(1):39-64. doi: 10.1007/s40368-021-00635-0. Epub 2021 Jun 10.
PMID: 34110615BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Restorative and Prosthodontics MSc.
Study Record Dates
First Submitted
November 30, 2025
First Posted
January 9, 2026
Study Start
January 10, 2026
Primary Completion
April 23, 2026
Study Completion (Estimated)
January 11, 2027
Last Updated
January 9, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared with other researchers. The study involves pediatric participants, and all data will be pseudonymized and stored in secure, access-restricted servers according to GDPR and local ethics requirements. Because the dataset is small, contains sensitive clinical information from minors, and is collected within a single clinical center, sharing IPD may increase the risk of re-identification. Therefore, IPD will not be made available outside the research team.